In this review, recent studies using pharmacological treatment, cell transplantation, and gene therapy to promote regeneration of the injured spinal cord in animal models will be summarized. Pharmacological and cell transplantation treatments generally revealed some degree of effect on the regeneration of the injured ascending and descending tracts, but further improvements to achieve a more significant functional recovery are necessary. The use of gene therapy to promote repair of the injured nervous system is a relatively new concept. It is based on the development of methods for delivering therapeutic genes to neurons, glia cells, or nonneural cells. Direct in vivo gene transfer or gene transfer in combination with (neuro)transplantation (ex vivo gene transfer) appeared powerful strategies to promote neuronal survival and axonal regrowth following traumatic injury to the central nervous system. Recent advances in understanding the cellular and molecular mechanisms that govern neuronal survival and neurite outgrowth have enabled the design of experiments aimed at viral vector-mediated transfer of genes encoding neurotrophic factors, growth-associated proteins, cell adhesion molecules, and antiapoptotic genes. Central to the success of these approaches was the development of efficient, nontoxic vectors for gene delivery and the acquirement of the appropriate (genetically modified) cells for neurotransplantation. Direct gene transfer in the nervous system was first achieved with herpes viral and E1-deleted adenoviral vectors. Both vector systems are problematic in that these vectors elicit immunogenic and cytotoxic responses. Adeno-associated viral vectors and lentiviral vectors constitute improved gene delivery systems and are beginning to be applied in neuroregeneration research of the spinal cord. Ex vivo approaches were initially based on the implantation of genetically modified fibroblasts. More recently, transduced Schwann cells, genetically modified pieces of peripheral nerve, and olfactory ensheathing glia have been used as implants into the injured spinal cord.
SPINAL CORD INJURY:
of spinal cord tissue. The interruption of the long descending and ascending spinal nerve tracts and of seg-CONSEQUENCES AND PHASES mental spinal neural circuitry causes severe loss of sen-The spinal cord is located in the vertebral column and sory and motor function. The loss of these vital funccomprises a large number of longitudinally and laterally tions is permanent, because spontaneous recovery of orientated nerve tracts connecting the brain with the injured spinal cord neurons does not occur. However, by neurons composing the peripheral nerves that innervate using physiotherapeutic approaches, some improvethe organs of the body. Spinal cord function is required ments have been observed, as the function of certain for voluntary movements of the limbs and trunk and for remaining neuronal circuits can apparently be enhanced transmission of sensory information from the skin, by training, both in rats (121, 122) and humans (218) . joints, and skeletal muscles to the brain. Fractures or
In contrast to neurons of the mammalian peripheral dislocations of the vertebra, usually caused by road trafnervous system (PNS) and developing central nerve fic, work or sports accidents, result in local compression tracts, injured adult central nervous system (CNS) neu-rons do not regenerate to any significant extent ( Fig. 1) . expresses several neurite outgrowth-inhibiting proteins (e.g., NI35/250 or nogo) (25, 29, 39, 80) and myelin-asso-Following injury to the adult spinal cord, cellular damage results in a cascade of events, including the release ciated glycoprotein (MAG) (46, 82, 152, 195) . Fluid-filled cysts, occurring within weeks after spinal cord injury, of excitatory amino acids, excessive cellular calcium influx, formation of free radicals, and activation of the form a permanent physical barrier for regenerative regrowth of injured neurites. immune system, leading to neuronal degeneration and cell death (97, 143, 189, 190) . Thus, the acute phase of In the injured PNS, the situation is different. Schwann cells (SCs) in the distal nerve stump form con-tissue loss is followed by secondary tissue destruction due to excitotoxicity, ischemia, and inflammation. Glio-tinuously aligned cellular structures known as the bands of Bungner. These facilitate the extension and guidance tic scar tissue is finally formed at the lesion site. Axotomized neurons form sprouts at the proximal site of the of injured nerve fibers. SCs display several properties that make them favorable to support regrowth of injured lesion, but they are stalled at the scar where they form characteristically enlarged nerve endings known as axons (104) . These include 1) the (re)expression of a variety of diffusable and contact-mediating growth-"end-bulbs." The scar is a complex cellular structure consisting of a core of fibroblasts and inflammatory promoting molecules, 2) their alignment, which provides regrowing neurites with natural cellular guidance chan-cells. Reactive astrocytes form the interface between intact nervous tissue and the primary lesion area. Several nels, and 3) the capacity to remyelinate regenerated axons. CNS neurons projecting through the spinal cord weeks after injury, cyst formation occurs at the site of the scar.
have the intrinsic capacity to regenerate their neurites as many populations of injured nerve fibers regrow into It is generally held that the failure of CNS axons to regrow and reestablish new neural connections is pri-peripheral nerve (44, 45, 68, 182) or SC implants (5, 34, 85, 107, 222) . The potency of CNS neurons to regenerate in marily due to the neurite growth-inhibitory nature of the CNS microenvironment and to a lack of effective neuro-a SC environment indicates that the failure of CNS neurons to regenerate is not primarily an intrinsic deficit of trophic support. All cellular elements of the scar express molecules with potential or proven neurite growth-inhib-these neurons (28) , but is predominantly due to environmental factors that either do not support or actively in-itory effects (61, 125, 142, 167, 197, 198) . The myelin-forming glia cells of the CNS, the oligodendrocyte, also hibit regeneration. The observation that spinal cord ax- ons, in principle, are able to regrow following lesions of the mammalian spinal cord, this dialog may be limited in lesions of untreated rats, thereby frustrating re-has brought optimism to the field of spinal cord regeneration.
generation in the spinal cord (125) . In summary, inflammation is a dual-edged sword that may be beneficial if PHARMACOLOGICAL AND well controlled (11).
ANTIBODY-BASED INTERVENTIONS
Reduction of Scar Formation Several pharmacological intervention strategies have been undertaken to target different aspects of the acute Initial attempts to reduce scar formation failed. These strategies included local implantation of gall bladder tis-and earliest chronic phase of the neural degeneration and repair process. These interventions include reduction of sue (containing digestive enzymes) and treatment with bacterial anti-inflammatory substances and trypsin (151) . glutamate-mediated excitoxicity, reduction of immune system-mediated swelling, the reduction of scar tissue Recent studies targeting specific cellular and molecular components of the scar have had more success. formation, blockade of growth-inhibiting effects, and addition of growth-stimulating proteins.
A major element of the neural scar is the so-called basal membrane (BM), consisting of infiltrating fibro-Excitotoxicity blasts and collagen type IV as anchoring component (99, 137, 199) . The BM develops within the first 2 weeks Following trauma of the adult spinal cord, excessive amounts of glutamate are released shortly after injury.
after transection of, for example, the postcommissural fornix of the adult rat. The spatiotemporal formation of To prevent the excitotoxic effects of released glutamate, agents were applied systemically to antagonize N-methyl-the BM coincides with the growth arrest of regrowing injured axons. Local injection in the injured fornix of D-aspartate (NMDA) receptor activity. These agents include dizocilpine (MK-801) (60,86), cerestat (CNS-collagen type IV antibodies or an inhibitor of collagen triple helix synthesis significantly reduced lesion-1102) (2,119), and gacyclidine (57, 63, 72) . All these substances exert beneficial effects on the survival of injured induced BM deposition. This treatment allowed massive axon elongation in and across the lesion site. Further-spinal cord tissue and on the recovery of function of the hind limbs. Although results have been promising, a more, regenerating axons followed their original pathway, reinnervated the appropriate target, the mammil-variety of expected side effects have inhibited the application of these agents in the clinic. lary body, and were remyelinated (199). In the injured rat spinal cord collagen type IV deposits apparently do Immune Response not prevent regrowing axons from penetrating the lesion site (108, 109, 217) . However, application of collagen Shortly after injury, the immune system is activated. type IV antibodies following rat spinal cord injury par-This causes swelling of injured tissue within the vertebra tially did prevent corticospinal axonal growth failure resulting in secondary tissue loss. To reduce immune (H. W. Müller, presented at the European Society for system-mediated swelling of the injured spinal cord, im-Neurochemistry meeting 2001, Perugia, Italy, and S. mune suppressants have been used. Methylprednisolone Hermanns, presented at the Society for Neuroscience and FK506 have been applied in several rat spinal cord meeting, 2001, San Diego, US). In addition to collagen injury models and indeed suppress the secondary neuand collagen-associated proteins, other molecules conronal necrosis (8, 163, 230) . In the United States, methyltribute to axonal growth failure and their actions must prednisolone is routinely applied to patients with spinal be blocked collectively to promote corticospinal regencord injury (20, 21) .
eration. Systemic administration of interleukin-10 (IL-10) also has a beneficial effect on recovery of hind limb Inactivation of Neurite Growth Inhibitors function of rats with spinal cord contusions (12). IL-10 is an anti-inflammatory cytokine that reduces tumor
The lack of regeneration is in part caused by neurite growth-inhibitory protein constituents of CNS myelin necrosis factor-α (TNF-α) synthesis by activated macrophages. Repair of injury in most tissues, however, also expressed near or at the lesion site. Local application of a monoclonal antibody (IN-1) directed against nogo-A, appears to require an effective dialog with macrophages. Following implantation of autologous macrophages that a myelin-associated inhibitor of neurite growth, in the hemisected spinal cord of rats resulted in regrowth of were preexposed to peripheral nerve pieces, regrowth of several fiber systems of the lesioned spinal cord has several fiber systems including those of the corticospinal tract (CST) (25, 29, 33, 39, 215) . This demonstrated that been observed. In addition, partial functional recovery of the hind limbs was observed in the animals with these the microenvironment of the scar can be modified to allow neuroregeneration. However, more than one inhib-implants (179, 191) . Due to the immune-privileged status itory factor seems to be involved because infusion of of neurotrophic factor administration can be tightly controlled. Various studies indicated that survival of injured IN-1 failed to induce regrowth of ascending fibers in the dorsal columns (163) . In addition to the repulsive effects CNS neurons can be achieved in this way. NT-3, BDNF, and NT-4/5 delivered intraparenchymally are shown to on axonal guidance, contribution of myelin-derived factors in the formation of the scar has recently been have a protective effect on injured rubrospinal neurons when applied at the level of the cell body (117, 157, 204) . demonstrated. Mice immunized with myelin developed a less robust scar following spinal cord lesion whereas Infusion of neurotrophins also prevented atrophy of the injured red nucleus neurons of the rubrospinal tract regrowth of some CST fibers was induced up to 11 mm distal from the scar (102) .
(RST) and induced the expression of intrinsic neuronal proteins such as growth-associated proteins B-50/GAP-Application of Growth-Promoting Molecules 43 and Tαa1-tubulin (117) . Application of NT-3, BDNF, and GDNF, but not NGF, was also shown to have a Neurotrophic factors are well known for their stimulating effects on neurite outgrowth (129, 212) . In the con-beneficial effect on the survival of injured CST neurons following infusion into the CSF (75-78). Other neuronal text of research on neuroregeneration one class of neurotrophic factors, the neurotrophins, has received most systems that benefit from neurotrophin application include a distinct subgroup of dorsal root neurons (10) attention. The neurotrophin gene family consists of nerve growth factor (NGF), brain-derived neurotrophic and motor neurons (154, 155, 187) . Axotomized neurons located in Clarke's nucleus can also be rescued for a factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4/5 (NT-4/5), and neurotrophin-6 (NT-6). Neurotrophins limited time following delivery of neurotrophins (156) . A pilot study in Alzheimer's disease patients treated exert their action through binding to specific tyrosine kinase transmembrane receptors (Trks). NGF binds to with low doses of NGF revealed side effects of direct protein infusion into the CSF, including pain and weight TrkA, BDNF and NT-4/5 bind to TrkB, and NT-3 preferentially binds to TrkC but has also affinity for TrkA loss (59, 153) . The side effects disappeared within a couple of days after terminating the NGF infusion and were and B. Furthermore, all neurotrophins interact with equal affinity to the p75 receptor (40,90). In addition to followed by weight gain.
To investigate whether the delivery of neurotrophins the neurotrophins, ciliary neurotrophic factor (CNTF) and glial cell line-derived neurotrophic factor (GDNF) would be able to stimulate regrowth of injured ascending axons, NT-3, NGF, and BDNF have been delivered have been shown to promote neuronal survival. Both CNTF and GDNF bind to multicomponent receptors via a minipump in the spinal cord. The application of neurotrophins, in combination with a conditioning lesion composed of CNTFRα, LIFRβ, and GP130 for CNTF (196) or GDNFRα and RET for GDNF (205) .
of the peripheral nerve, resulted in regrowth of injured sensory fibers (9, 161, 162, 221) . In a dorsal root injury The use of neurotrophins is a promising strategy to promote regeneration of CNS neurons and repair the model, intrathecal delivery of NT-3, NGF, and GDNF, but not BDNF, resulted in regrowth of axons across the damaged spinal cord. A major problem of neurotrophic factor application is the difficulty of delivering these otherwise refractory dorsal root entry zone and in functional synaptic reconnection. Rats treated with NGF and proteins to the injured CNS in biologically relevant amounts and for prolonged periods of time. Because GDNF recovered sensitivity to noxious heat and pressure (172,173). Finally, in a rat spinal root avulsion neurotrophins have a very short half-life, are digested in the gastrointestinal tract, and do not pass the blood-model, BDNF promoted survival and subsequent regeneration of injured motor neurons (115). The limitation brain barrier, oral or systemic administration is fruitless. This limitation has led to various methods for direct of intrathecal infusion is the poor diffusion of most neurotrophic factors into the CNS parenchym. Leakage to neurotrophic factor delivery to the spinal cord. These include: 1) protein delivery to the cerebrospinal fluid neuronal systems that should not be affected is also one of the concerns. Side effects caused by the sprouting of (CSF) or intraparenchymally, 2) neurotrophic factor gene delivery to injured spinal cord tissue using viral other (intact) neuronal systems may result in gait disturbance and even weight loss (53) . Finally, intraparen-vectors, and 3) the implantation of cells genetically engineered to secrete neurotrophic factors. Each of these chymal delivery, with cannula insertion and infusion, causes tissue damage (161) . strategies has specific advantages and disadvantages that will be discussed below and in the section "Gene Thera-Implantation of slow-release materials provides another tool for local application of bioactive molecules. peutic Approaches."
Advantages of direct neurotrophic factor delivery to A collagen matrix soaked in BDNF and implanted at the site of hemisection of the spinal cord resulted in less the CSF by means of intracerebroventricular, intraparenchymal, or intrathecal infusion in the CSF of neuro-initial tissue loss and loss of hind limb function (101) . In this study, protection from secondary damage rather trophic factors are that both the amount and the duration than stimulation of axonal regeneration enhanced func-functions (169) and rhythmic motor behavior (64,181, 225). Thus, function partially recovered by transplanta-tional recovery. Following collagen-mediated NT-3 delivery, enhanced regeneration of the CST and improved tion of supraspinal neurons at or distal from the lesion site, but the effect appears to be based on the stimulation function of the hind limbs were observed (100) . Direct application of neurotrophic factors via saturated gelfoam of reflexive movements. Transplantation of fetal spinal cord tissue in the tran-stimulated regeneration of several descending tracts (such as the RST, and some tracts that originate in the sected spinal cord was not only intended to provide a bridge for axonal connectivity between the proximal and brain stem) (14, 188, 229) . The implantation of slow release materials causes in principle minimal tissue dam-distal lesion sites but also to reconstruct the cytoarchitecture and anatomy of the damaged site (27, 134, 180 , age, but the control of a steady and continuous neurotrophin release remains problematic (50) . 203, 208) . Fetal spinal cord grafts survive well and become fully integrated when placed in the completely
CELLULAR INTERVENTIONS
transected spinal cord of neonatal rats (49) . Bregman et Various types of cellular implants in spinal cord al. (24) showed that fetal grafts placed in young animals, injury models have been developed to study different in contrast to implantation in older animals, resulted in aspects of repair. First, fetal spinal cord tissue was imregrowth of supraspinal CST axons. Fetal spinal cord planted as a bridge for axonal reconnection of the grafts placed in the lesioned spinal cord of adult rat also stumps and for reconstruction of segmental neural cirestablished graft-to-host connections (4,146) and atcuits. Second, fetal supraspinal neurons were grafted tracted ingrowth of axons of local neurons but failed to distal to the lesion in order to restore the lost supraspinal show prominent ingrowth of supraspinal axons (4,106). input of the denervated spinal cord. Third, peripheral These grafts, moreover, prevent retrograde cell death nerve or SC implants were employed to allow regeneraand atrophy of the supraspinal neurons of the RST (23, tive growth of descending and ascending axonal connec-146). The poor ingrowth of supraspinal serotonergic, tions across lesion cavities. Recently, olfactory ensheatnoradrenergic, and CST axons could be stimulated by ing glia (OEG) were applied to reach this goal. Fourth, early local administration of BDNF, NT-3, and NT-4, embryonic stem cells were implanted as an attempt to but not CNTF, at the lesion/implantation site. However, locally reconstruct the injured spinal circuitry. Fifth, cell none of these supraspinal axons passed through the lines were used as source for cellular replacements.
transplant into the distal intact spinal cord (26) . Indeed, Finally, implants of genetically modified fibroblasts or it has been shown in other CNS injury models that re-SCs were implanted as biological minipumps for local growing axons may preferentially innervate fetal target delivery of neurotrophic factors to promote cell survival neurons. Hence, they do not continue to regrow through and to promote and guide neurite regrowth (see Fig. 2 ).
the graft towards their host CNS targets (88, 89) . Taken together, these results indicate that both short-distance Fetal Nervous Tissue ascending and descending host-to-graft connections are made by fetal cord-grafted neurons and that the graft-to-The use of fetal neural tissue for spinal cord repair falls into two categories: 1) to promote reinnervation of host fiber ingrowth may develop to serve as a "relay" function for the transplant. the distal spinal cord with supraspinal input and 2) to provide a cellular substrate that acts as a bridge that can Peripheral Nerves and Schwann Cells possibly also reconstruct lost segmental circuits.
The allografting of fetal supraspinal neurons was The vigorous regrowth of axons in the PNS contrasts with the nonregenerative properties of the CNS. David prompted by observations that noradrenergic and serotonergic agonist treatment activated stepping movements and Aguayo (44) were the first researchers to systematically exploit peripheral nerves as bridges in the injured of spinal tract-lesioned rats (32, 65) . It was hypothesized that this effect was due to the activation of the dener-rat spinal cord. Ingrowth of fibers both from the proximal and the distal site of the lesion cavity indicated that vated spinal generators of locomotion in segmental circuits. The spinal pattern generator of locomotion is able central neurons regenerate in a peripheral SC environment. However, fibers never passed the second implant-to generate reflective walking movements of the hind limbs in response to tactile stimulation. Supraspinal de-host interface, so that the distal and proximal stumps were not reconnected by regenerating descending or as-nervation blocks the generation of these intentional movements (36, 51, 181, 194, 202) . Fetal locus coeruleus cending fibers. Later studies confirmed these observations (37,99), as well as studies applying SC-seeded tissue grafted distal from a spinal cord lesion and reinnervating the spinal cord indeed improved stepping be-guidance channels instead of peripheral nerve pieces (34, 222, 224) . Also, upon the local application of IN-1 havior in a treadmill (225, 226) . Similarly placed grafts of serotonergic raphe neurons restored sexual reflex antibodies against the neurite growth-inhibiting protein Nogo-A, no fibers completely crossed the gap via these on Hoechst labeling, OEG are reported to migrate away from the injection site as if they continuously follow SC cables (84, 163) . The additional local infusion of neurotrophic factors like NT-3 or BDNF in the SC implant and support the regenerating axons (83, 105, 159) . Recently, however, p75 immunolabeling of transplanted increased fiber growth in SC implants (223) and more recently it was reported that neurotrophin infusion in-OEG showed that the implanted cells do not migrate beyond the scar and that the Hoechst label possibly leaks duced axonal passage through the implant (5).
Supraspinal fibers, including those of the CST, were from implanted cells (185) .
Using porcine OEG xenoimplants in lesions of im-reported for the first time to traverse into the dorsal stump using a surgically very delicate approach whereby munosuppressed rats, impulse conduction across the injury was restored across and beyond the lesion site, with 18 intercostal nerve autoimplants bridge the proximal white matter to the distal gray matter at the spinal cord conduction velocity being even faster than that in normal axons. The latter observation is possibly related to injury site (41) . This study combined the effects of guidance and trophic support of SC-containing peripheral the relatively thick peripheral nerve-like myelination (6, 67, 105, 111) . Injection of primary adult OEG in uni-nerve implants and the permissive properties for axonal regrowth of the spinal cord gray matter. The proper rout-laterally CST-lesioned rats induced extensive growth of the injured axons that continue to elongate distal of the ing of white to gray matter of the bridges, together with the use of acidic fibroblast growth factor (aFGF), implant into the intact distal spinal cord (128). Regrowth was associated with recovery of directed paw-reaching appeared the key requirements for the reported effects. Improved hind limb function was established in these behavior. Ramón-Cueto et al. (175) recently reported that OEG injections 1 mm distal and proximal to the animals during a period of 12 months. Follow-up studies of this promising approach have, however, not been lesion site led to a spectacular functional and structural recovery in the complete spinal transection of adult rats. published.
From 3 to 7 months postsurgery, animals recovered with Olfactory Ensheating Cells voluntary hind limb movements, showed body weight support and sensorimotor reflexes. Motor axons of the Over the past few years there has been an increasing interest in using other glial cell types as a strategy to corticospinal, raphespinal, and coerulospinal tract were reported to regenerate over long distances. Strikingly, repair the injured spinal cord. Guided by studies with SC implants, more recent studies in spinal cord repair after crossing the distal glial scar, these fibers elongated in white and gray matter, reaching 1.5 cm distal from research employed olfactory ensheating glia (OEG). Neurons of the olfactory system are continuously re-the lesion (the furthest distance analyzed). Long-distance regeneration (at least 2.5 cm) of injured ascending newed and axonal growth occurs along OEG, a unique glial cell type only present in this part of the adult CNS propriospinal axons was observed in the rostral spinal cord (175) . Following complete spinal cord lesion, (7, 55, 56, 66, 171, 176) . The unique property of OEG to guide axonal regrowth in the CNS and the relative ease supraspinal tract regeneration was also observed when OEG were injected at both stumps connected with a SC-to culture and expand OEG (228) make them interesting cellular conduits to promote neuroregeneration in the filled guidance channel (177) . The OEG penetrated the scar, forming a path for axonal regrowth to and across CNS.
Following rhizhotomy (and reanastomosis) of a the SC bridge for the regrowing supraspinal serotonergic axons. Ascending axons also crossed the bridge and re-spinal segment, dorsal root axons were able to regrow along the injected trail of OEG into the otherwise refrac-generated into the proximal stump. This approach is very promising as it combines the growth-promoting tory spinal cord. The implanted OEG reached the same laminae as the regenerated axons, indicating their impor-properties of SCs and the scar-penetrating properties of OEG. tance to chaperone regrowing neurites (150, 176) . Based FACING PAGE Figure 2 . Continued. factors (for instance NT-3) from (genetically engineered) implanted cells. (D) Implanted OEG have the unique property that they migrate through the scar. By migrating through the scar, these cells penetrate the scar, and support axonal regrowth over this barrier. (E) Sites for vector-mediated trophic gene transfer. The cell body of the injured neuron can be transduced to express genes that promote survival and reverse atrophy. Genes that are part of the genetic program that favors regrowth of axons may also be introduced. Also implanted cells can be transduced in order to secrete trophic factors that enhance neuritic outgrowth. The nonpermissive scar is also a possible intervention site to overexpress factors that are favorable for axonal regrowth or diminish growthinhibitory factors. Finally, target cells distal to the implant may be transduced to attract fibers towards these cells or to enhance the formation of new synapses.
BLITS, BOER, AND VERHAAGEN

Embryonic and Neural Stem Cells
fore investigating alternative sources of tissue and/or cells to replace lost neurons. Immortalized neural cells The isolation of pluripotent embryonic and multiprovide an additional and unlimited source. Many differpotent neural stem cells has lead to new strategies toent cell types have been used [reviewed in (219) ]. The wards repair of CNS injury. Several types of stem cells advantage of cell lines is that these cells can be well have been isolated that undergo self-renewal and can characterized in vitro and in principle available ad libidifferentiate in different neural phenotypes in vivo and tum. Furthermore, they offer an excellent cellular platin vitro (54, 124, 136, 138, 139, 178, 201) . For example, imform for ex vivo gene therapy. These cells generally planted embryonic stem cells are capable of differentiamaintain the capacity to differentiate into neurons, astrotion into neurons and glia in the brain (52) and in the cytes, and oligodendrocytes despite continued passage spinal cord (140) , as do neural stem cells from fetal in cell culture (219) . origin (31) . Neural stem cells can also be obtained of Onifer et al. (160) implanted RN33B cells in normal, astrocyte monolayers from the mouse cerebral cortex, kainic acid-lesioned, motor neuron-depleted, and trancerebellum, spinal cord, and special areas of the subsected adult rat spinal cord. These cells differentiate into ependymal zone (SEZ). These cultures can form neuneurons following engraftment in the spinal cord. Howrospheres under certain conditions that give rise both to ever, in all lesioned spinal cords, cells did not differentineurons and glia. The ability to form neurospheres, howate with the complex neuronal morphologies seen in the ever, is restricted to astrocyte monolayers derived up to uninjured spinal cord. Their differential restriction after the first 2 postnatal weeks, except for SEZ astrocytes, transplantation into the lesioned spinal cord may reprewhich retain this capacity in the mature forebrain. Folsent intrinsically distinct physiological properties. Lee lowing implantation, stem cells not only differentiate but and coworkers (126) implanted a human neuron cell also migrate away from the injection site (88) . Recently, line, NT2N, into the mouse spinal cord. A slight imstem cells from nonneural sources (e.g., bone marrow) provement of hind limb function was observed. No synhave been shown to migrate into the brain after being aptic integration of NT2N cells was observed, so they injected into the circulation and develop into neurons likely function through the release of neuroprotective or and oligodendrocytes (22, 144) . A major concern with trophic molecules that affect endogenous neurons, rather using embryonic stem cells, not neural stem cells, is the than to reinstate host circuitry. While this is an imporpossible formation of tumors. So far, most neural protant repair mechanism, it limits their use to injury paragenitor cells, isolated from the adult CNS, differentiate digms that do not require the functional replacement of into oligodendrocytes and astrocytes and not neurons lost neurons. following implantation into the spinal cord (38, 69, 70) .
The multipotentiality of many immortalized cell lines In vitro differentiated stem cells have recently been in vivo demonstrates that they can appropriately respond shown to participate in the repair of spinal cord defects.
to epigenetic signals from the host CNS. Secondly, these Demyelination of spinal cord axons can be reversed by data confirm that adult CNS tissue continues to express implantation of oligodendrocytes differentiated from those signals and can direct very specific and regionally neural stem cells (30,133). Neural differentiated embryappropriate differentiation of those engrafted cells. Lasonic stem cells implanted 9 days after a contusion lesion tly, some neural cell lines can recognize microenvironof the spinal cord resulted in amelioration of weight-supmental signals from the lesioned adult CNS and preferported stepping of the rats. This was not observed in the entially differentiate along a lineage that is essential for sham-implanted animals (140) . The mechanism of the latrepair: an important aspect considering the actual cliniter effect is not yet clear as no anatomical staining or traccal situation following injury. At the same time there are ing has been reported of these animals. An inhibiting efclear conceptual concerns with the use of human-derived fect on lesion-induced demyelination by the stem cellcell lines, because of the possible formation of tumors. derived oligodendrocytes has been proposed as an expla-Ultimately, the utility of a given cell line to replace lost nation (139), but the differentiation of stem cells into cateneurons in a specific injured CNS environment will have cholaminergic neurons and subsequent permissive effects to be empirically determined. on the spinal pattern generator is another proposition (170) .
GENE THERAPEUTIC APPROACHES Cell Lines
As discussed above, attempts to demonstrate robust and persistent beneficial effects of neurotrophic factors The ethical (95) and logistical (220) issues involved in obtaining sufficient quantities of human donor tissue following local administration to the injured spinal cord have had some success. Local administration of neuro-of appropriate age and of particular regions of the nervous system limit the widespread therapeutic use of fetal trophic factors, however, so far never resulted in complete return of function. Analysis at the anatomical level cell transplantation in patients with brain injuries or with neurodegenerative diseases. Many laboratories are there-demonstrates that the number of regenerated axons is only a small proportion of the total number of lesioned line neurotransmitter phenotype of the lesioned cells (227) . So far no other work with HSV vectors has been nerve fibers. One reason for this might be that local application of neurotrophic factors does not lead to optimal reported to promote regeneration of the spinal cord. exposure of the affected neurons to the neurotrophic fac-Adenoviral Vectors. First-generation adenoviral vector. The delivery of therapeutic proteins can also be tors have been used to transduce the intact spinal cord achieved by transducing the cells in the spinal cord close following intrathecal or intraparenchymal injection (130, to the injured axons or by transferring genes to supraspi-135,158). After injection into the mid-thoracic spinal nal neurons in the brain with the use of viral or nonviral cord of adult rats, transgene expression was reported in vectors. Vector-mediated expression of neurotrophic neurons and glial cells around the injection site but also factors to the spinal cord has several advantages over in neurons whose axons project to the region of injeclocal or systemic administration of the neurotrophic faction. For instance, labeled neurons were observed in the tor itself. First, vectors can be delivered to the brain or red nucleus, the vestibular nuclei, the reticular formaspinal cord by means of a single stereotactic injection, tion, locus coeruleus, and Clark's nucleus. Intrathecal thus minimizing neurosurgical intervention. Second, exinjection in the sacral region of the spinal cord resulted pression via a vector can be directly targeted to the cell in high levels of transgene expression in the meninges, bodies of the affected neurons or to cells in or around in particular around the site of injection, but also at the the lesion site. This ensures local expression of the neuthoracic and lumbar levels. After both intrathecal and rotrophic factor and reduces side effects of the trophic intraparenchymal injection, transgene expression defactor on neurons that are not affected by the lesion.
clined significantly from the second week onwards. This Third, the expression of a neurotrophic factor via a vecis due to an immune response that was also noted tor mimics their physiological production. Several following the injection of first-generation adenoviral vector systems, all with their inherent advantages and vectors in the brain (35,91,92) . The immune response disadvantages, are available. These vectors range from triggered by adenoviral vectors was characterized by nonviral vectors (e.g., DNA molecules encapsulated in upregulation of MHC class I and II antigens and the liposomes) (46) to virus-based vectors systems, includinfiltration of activated T-lymphocytes and macroing vectors based on herpes simplex virus (HSV), adephages. Cyclosporin A and dexamethasone treatment novirus, adeno-associated virus (AAV), and lentivirus can prolong transgene expression in the brain and spinal (LV) (94) .
cord (93, 130) . In T-cell-deficient nude rats transduced astrocytes survive for several months but transduced Direct Gene Transfer neurons degenerate (92). A temperature-sensitive adeno-Herpes Viral Vectors. Federoff and colleagues (62) viral vector with reduced expression of late viral prowere the first to construct and apply viral vectors for teins at the nonpermissive temperature has also been neurotrophic factors. A defective HSV vector for NGF used as a backbone to create a recombinant adenovirus (pHSVngf) was used to demonstrate efficient expression (58) . A combination of the use of temperature-sensitive of biologically active NGF in the rat superior cervical recombinant vectors and immune blockade led to an enganglion. pHSVngf infusion in an axotomized sympahanced stability of transgene expression up to 60 days thetic ganglion prevented the previously shown decline postinjection (183) . Taken together, these results suggest in tyrosine hydroxylase expression that normally occurs that recombinant adenoviruses can be used for in vivo after axotomy of sympathetic neurons (62) . The same delivery of therapeutic genes to support neuronal survector was used to show that primary sympathetic neuvival and axonal regeneration. However, the immune rons in culture survived following transduction with response elicited by these vectors after injection in the pHSVngf without addition of NGF to the culture menervous system and the direct toxicity of these vectors dium (73,74). In another study, a defective HSV vector to neurons continues to be a problem, and limits possible encoding BDNF was used to induce neurite outgrowth applications in human CNS repair. Nevertheless, a numin cultured auditory ganglia (73). BDNF and NT-3 are ber of studies using adenoviral vectors have provided the natural neurotrophins for neurons constituting the proof of principle for the effectiveness of viral vectorauditory ganglion. These neurons utilize these factors to mediated overexpression of neurotrophic factors to promaintain their function in the mature ear and a viral vecmote neuroregeneration. tor encoding BDNF may be used in the future to study Transduction of the injured spinal cord using adenoits value in promoting regeneration of the innervation of viral vectors has been achieved both distal to the lesion the ear (211) .
(17,130) and at the lesion site (103) . When adenoviral Recently, HSV vector-mediated expression in the rat vectors encoding the reporter gene LacZ were injected spinal cord of Bcl-2 was reported at 1 week prior to 5 mm distal to the hemisected spinal cord directly follesioning of spinal roots. This prevented the motor neulowing lesion, transduction largely failed and was only seen in cells surrounding the needle tract. Injection of rons to atrophy but was not able to preserve acetylcho-adenoviral vectors distal to the lesion resulted in robust of transgene expression, causing significant improvements in behavioral responses (183) . expression when performed at 1 (Fig. 3) or 2 weeks postinjury (130) . The observed differences in transduction The adenoviral vector system has also been used to study the function of other cell adhesion molecules, efficiency are probably due to clearance of the vector resulting from fluid currents and the activation of the NgCAM and axonin-1/TAG-1, in primary neuronal cultures and in vivo. Following transduction of dissociated immune system following lesion.
In a dorsal root lesion model, Zhang et al. (231) in-rat dorsal root ganglion cells newly synthesized NgCAM and axonin-1 are directly transported to the growth cone, vestigated whether transduction of the ventral horn with an adenoviral vector encoding the NT-3 gene might of-where they are incorporated in the growth cone membrane. This shows that the array of cell adhesion mole-fer an approach to stimulate the reingrowth of dorsal root sensory axons. These axons do not normally regen-cules is continuously refreshed at the axonal tip and suggests that the adhesive properties of growth cones erate beyond the dorsal root entry zone, but following injection of the vector they regenerated in the gray mat-can be modified by changing the composition of adhesion molecules of the growth cone (79, 214) . ter as deep as lamina V. In another study, Romero et al. (183) showed that following injection of the adenovector Adenoviral vectors have also been used to study the biological activities of B-50/GAP-43, an intraneuronal encoding NGF, extensive spouting occurred throughout the entire dorsal horn, extending into the ventral horn membrane-associated growth cone protein with a role in axonal growth and regeneration. ated and cell adhesion molecules will permit genetic area of the motor neuron pool of the spinal cord reduced motor neuron loss following ventral root avulsion (Blits manipulation of their expression in regenerating neural systems in vivo to study their role in growth cone move-et al., unpublished). AAV-BDNF-and AAV-GDNFtreated animals showed increased survival of ChAT-ment, sprouting, and path finding. Despite all these positive effects, however, direct in vivo application of HSV stained motor neurons as well as stimulated sprouting; however, they were limited to the area of transduction. and adenoviral vectors is not a choice for therapy as the vectors cause inflammatory responses and are cytotoxic Another study applied B-50/GAP-43 as intrinsic determinant of axonal regeneration using recombinant AAV following direct intraparenchymal injection (91) .
vectors. Vectors encoding rat B-50/GAP-43 injected into Adeno-Associated Viral Vectors. AAV vectors are the substantia nigra pars compacta directed expression not cytotoxic nor do they elicit a detectable cellular imof B-50/GAP-43 in both dopaminergic and nondopaminmune response following in vivo injection. Peel and colergic neurons for 3 months. Transduction with the B-50/ leagues (168) presented long-term transgene expression GAP-43 vector in this region resulted in B-50/GAP-43following injection of a recombinant AAV vector in the positive axons that formed clusters of aberrant network naive spinal cord. The transgene was expressed under of neurites (116) . Because, in contrast to Ad and HSV control of the neuron-specific enolase promoter. Expresvectors, AAV vectors lack detectable cytotoxic effects, sion of green fluorescent protein (GFP) persisted for at AAV vectors are currently the vector of choice for gene least 25 months in rats without signs of toxicity, a findtherapy in patients. ing recently confirmed by us ( Fig. 4) . Recombinant AAV vectors therefore provide a reliable approach to Lentiviral Vectors. Another vector that recently became available is the LV vector based on the human transduce the neurons in the adult CNS.
The potential of gene delivery by AAV vectors to immunodeficiency virus (HIV). LV vectors have a relatively large transgene insertion capacity of approxi-promote neuronal regeneration has been presented in several studies. First, in a transgenic mouse model for mately 9 kb DNA and can infect and stably transduce dividing as well as terminally differentiated cells (19,43, amyotrophic lateral sclerosis motor neuron survival and improved neuromuscular functioning was demonstrated 47, 110, 112, 118, 145, 148, 149) . The efficiency and stability of LV infection was investigated in the striatum and after AAV vector-mediated expression of Bcl-2 (3). The same antiapoptotic factor has also been used to prevent hippocampus of the rat brain. Performance of the LV vector was compared to AAV and adenoviral vectors. atrophy in rubrospinal tract neurons (186) . Second, AAV vector-mediated overexpression of BDNF in red nucleus Both AAV and LV vectors did not induce a significant immune response, whereas adenoviral vectors did. LV neurons reversed spinal cord lesion-induced atrophy when applied at the time of injury (184) . Third, AAV-and AAV vector-mediated transgene expression lasted for at least 24 weeks (18) . A single injection of a LV mediated overexpression of GDNF and BDNF in the vector encoding GDNF was capable of preventing cell NGF-producing implants in dorsal hemisection lesions of the spinal cord attracted significantly more ingrowth death in the facial nucleus that occurs following lesion close to their cell bodies (98) . Using a rat model of Par-of sensory neurites and coeruleospinal noradrenergic neurites than control implants. Sensory dorsal root neu-kinson's disease, recent experiments have shown that adenoviral, AAV, and LV vector systems are effective rites penetrated densely in NT-3-and bFGF-producing implants and a sprouting effect of the local motor neu-for long-term delivery of GDNF in the nigrostriatal system. Injection of GDNF vectors in the striatum, in par-rons was observed. Implants of SCs modified to release NGF resulted in similar effects in the injured spinal cord ticular, is effective not only in rescuing the cell bodies in the substantia nigra but also in preserving the nigro-as NGF-overexpressing fibroblast implants (210) . Improved functional recovery has been reported us-striatal projection and a functional striatal dopamine innervation in the rat Parkinson model. Long-term ex-ing implants of neurotrophin-releasing cells in spinal cord-lesioned rats. Implantation of NT-3-producing fi-periments using AAV-GDNF and LV-GDNF vectors show that sustained GDNF delivery over 3-6 months broblasts in the lesion cavity of hemidorsal-lesioned spinal cord resulted in significant improvements in a motor can promote significant functional recovery in both 6-OHDA-lesioned rats and MPTP-lesioned monkeys grid task (81) . However, CST axons did not penetrate the implant, but an augmented regrowth of fibers at and (13, 114) . So far, LV vector-mediated transduction of intact or injured spinal cord has not been reported. Also, far distal to the lesion site was observed through the spared ventral gray matter. Implantation of genetically as with AAV vectors, LV vectors do not display detectable inflammatory or cytotoxic responses and could engineered fibroblasts producing NGF or BDNF in the area of a contusion lesion of the spinal cord also acceler-therefore be a good choice for future gene therapy studies.
ated recovery of hind limb function (113) , as was reported for NT-3/collagen implants (100) .
Nonviral Vectors. Nonviral vectors have rarely been
Ex vivo adenoviral vector-mediated gene transfer was used in neuroregeneration studies. The reason for this is also used to transduce peripheral intercostal nerve that nonviral gene transfer to the nervous system is very autoimplants. Transduced intercostal nerves were used inefficient (123) . Saavedra et al. (186) recently reported to bridge a hemidorsal spinal cord lesion in order to prothat transduction of injured neurons was possible by mote CST regeneration (16, 17) . Untransduced or Adapplying DNA complexed with cationic lipids. A single LacZ-transduced implants displayed ingrowth of many injection at the lesion site of a RST lesion resulted in fibers from the host spinal cord, but axons of the CST retrograde transport of DNA to the perikarya of the red fail to regenerate into the intercostal nerve graft. Instead nucleus. Overexpression of the antiapoptotic protoof growing into the implanted nerve bridge, the CST oncogene Bcl-2 reversed the atrophy of the injured red axons grew underneath the implants in the spared gray nucleus neurons. These results indicated that intraspinal matter. Using intercostal nerves that were ex vivo transadministration of the Bcl-2 gene can prevent retrograde duced by an adenoviral vector encoding NT-3 (Adcell loss and reduce atrophy of axotomized red nucleus NT-3), at 16 weeks postimplantation, approximately neurons in adult rats and provide an effective means to three-to fourfold more of the anterogradely traced CST rescue neurons whose survival depends on different fibers had regrown their axons through gray matter begrowth factors (186, 193) .
low the lesion site compared with the number in control Ex Vivo Gene Therapy animals. Regrowth of CST axons occurred over more than 8 mm distal to the lesion site. However, no regener-In the ex vivo gene therapy strategy, cells or tissue are genetically modified in vitro and then implanted into ating CST axons were observed in the transduced peripheral implant. Animals implanted with an Ad-NT-3-the area of interest (i.e., the injured spinal cord). Cellular implants can be used to replace lost cells or can serve transduced peripheral nerve also exhibited improved function of the hind limbs (16) . These results were ob-as matrix to support regeneration of injured axons. When the implanted cells are genetically modified to tained irrespective of the fact that these autoimplants generated nanogram amounts of NT-3 per day for a 2-express a therapeutic gene, such as neurotrophin genes, the secreted transgene product should help to stimulate week period only (17). Thus, transient overexpression of NT-3 in peripheral nerve tissue bridges is apparently regenerative neurite outgrowth and reestablish neuronal connections.
sufficient to stimulate regrowth of CST fibers and to promote recovery of hind limb function. Taken together, Implants of primary fibroblasts genetically modified to secrete either NGF, BDNF, NT-3, LIF, or bFGF were combining an established neurotransplantation approach with viral vector-mediated gene transfer promotes the used to study the regenerative responses of supraspinal and segmental tracts to these neurotrophic factors in regrowth of injured CST fibers through gray matter and improves the recovery of hind limb function. the spinal cord (1,15,87,131-133,147,192,206-210,216 ). Implantation of OEG presently appears one of the bridged by regrowing nerve fibers are orders of magnitude larger than in rats. most promising strategy to augment long-distance regeneration in the injured spinal cord (see before). Yet
Observations in rats are significant in that they may point the way to new repair strategies in humans. Im-the number of axons that regrow and reconnect is still limited. Transduction of these cells to upgrade them to plantation of SCs, peripheral nerves, OEG, fetal spinal cord tissue, fetal brain grafts of long descending neu-deliver neurotrophic factors may be a valuable strategy to enhance the regenerative properties of these cells.
rons, neural cell lines, or neural stem cells, as well as the transfer of therapeutic genes (experimental gene OEG implants subjected to adenoviral vector-mediated gene transfer resulted in high levels of transgene expres-therapy) to the injured spinal cord, are all relatively new developments. The first study on the beneficial effects sion in both intact and injured spinal cord (185) . Expression declined between 7 and 30 days postimplantation in the rat of SC implants on spinal cord repair was published in 1981 (34, 44, 120) . Many, but not all, injured as a result of proliferation of OEG. The use of a LV vector encoding the marker gene GFP resulted in stable fibers can enter the implant, but the regenerating fibers failed to reenter their original white matter tract at the transduction for at least 4 months postimplantation (185) . This opens new possibilities for further studies distal end of the SC transplant. Scar tissue is surrounding the SC transplant and this is a so far untractable aiming at advantageous effects on regeneration following injury towards therapy.
problem. It is one of the main reasons why this work has not been pursued in primates or humans.
SUMMARY AND FUTURE DIRECTIONS
The continued search for cell types that can overcome this problem has recently resulted in the discovery that Neurons that give rise to the long descending and ascending tracts of the spinal cord normally survive fol-implants of OEG promote regrowth of nerve fibers through inhibitory scar tissue (128,150,174-177). These lowing spinal cord injury. The functional deficits of controlling the lower parts of the body that occur after a cells intermingle with scar cells and form scaffolds around regrowing nerve fibers, apparently shielding spinal cord lesion are thus mainly due to axonal injury rather than nerve cell death. Spinal cord injury is there-them from the hostile scar environment. Can these cells be used in future repair of the human spinal cord? OEG fore a disease of neuronal disconnection. The primary goal of research on spinal cord regeneration is to find have been cultured from human postmortem olfactory bulb. Determining the conditions for the growth and ways to promote functional reconnection of spinal axons. Future therapeutic repair strategies should allow expansion of human OEG in vitro is ongoing in several laboratories. Experiments with OEG from rhesus mon-formation of sprouts by the cut axon tips that cross the lesion site, extend over some distance into the cellular keys suggest that it is feasible to study the properties of these cells following implantation in the nonhuman environment of the spinal cord, and form functional synaptic connections. In view of the complexity of neuronal primate spinal cord (Ramon-Cueto, unpublished results presented at the Mickeln symposium on Neuroregenera-circuits, it would probably be unrealistic to expect complete restoration of the original neuronal connections by tion, Dusseldorf, May 2001). We have recently shown that rat OEG can be transduced with LV and adenoviral any therapeutic strategy. However, partial restoration of severed anatomical connections can already result in sig-vectors (185) . This opens the way to use these reparative cells as a cellular platform for ex vivo gene transfer. nificant functional benefit for patients.
Why is repair of the injured human spinal cord so In effect, this combines the outgrowth promoting and migratory properties of OEG with the possibility to difficult to achieve? As pointed out in a recent review by Raisman (171), there is a limit to the validity of repair overexpress additional therapeutic factors (e.g., neurotrophins). experiments in the rat spinal cord for the human condition. Most cellular, molecular, or other interventions do Direct viral vector-mediated gene transfer into the nervous system was first reported in 1988 using a HSV lead to some degree of functional recovery in the rat. Experiments in rats are executed in animals subjected to vector (165). In 1998, direct adenoviral vector-mediated expression of NT-3 to promote regeneration of injured acute lesions and are usually short term (in the range of weeks or months). Human injuries are chronic because spinal roots demonstrated the value of gene therapybased experimental repair strategies in the spinal cord humans with spinal injury may live on for several decades. Rats of 2-3 months of age have a relatively high (231). The purpose of these studies was to show that a viral vector could be used to introduce and express a capacity for spontaneous recovery compared with adult humans. The anatomical blueprints of the rat and human biologically active therapeutic gene into the nervous system. The HSV and adenoviral vectors used in these ini-spinal cord are quite similar, but the rat spinal cord is much smaller than the human spinal cord. Therefore, in tial studies cause significant tissue damage at the site of injection. The toxicity of these vectors hampered their the human spinal cord the distances that have to be application in studies that have the aim to repair nervous tor by these cells stimulates regrowth. SCs are able to remyelinate regrowing fibers. However, genetically system injury: they probably inflict more damage than repair. Long-term local overexpression of a therapeutic modified SCs are also encapsulated by scar tissue as wild-type cells. As described above, this problem may gene in the adult nervous system has until recently not been much more than a dream. It took 10 years of work have been solved by using OEG and future studies on this interesting glia cell will reveal its real value as a to develop AAV and LV vectors that could be used in neuroregeneration research. These vectors allow long-reparative cell. term expression of a therapeutic gene in neurons and REFERENCES glia without detectable signs of toxicity. However, longterm expression of neurotrophins may cause side effects the use of human brain tissue are required. In order to
